Two British and American pharmaceutical companies have insufficient vaccine supply in many EU countries: unacceptable

　　China News Service, January 25. According to Hong Kong’s “Wen Wei Po” report, after the US pharmaceutical company Pfizer stated that it would reduce the supply of the European Union’s new crown vaccine, the British pharmaceutical company AstraZeneca also said recently that due to factory capacity problems, the first batch of supplies was supplied to the EU The dose of the vaccine will be reduced by 60%, causing dissatisfaction in many countries, and Italy even threatened lawsuits.

In January and September local time, Cannes, France, the COVID-19 vaccination center in the Cannes Film Palace began to open.

The picture shows medical staff vaccinating the new crown vaccine at the new crown vaccination center in the movie palace.

　　The European Union is expected to approve the emergency use of the new crown vaccine jointly developed by AstraZeneca and Oxford University on the 29th of this month.

However, an AstraZeneca spokesperson said that due to the reduced production capacity of a factory in Belgium, the initial vaccine production will be lower than expected.

　　The source pointed out that AstraZeneca was originally scheduled to supply 80 million doses of the new crown vaccine to the EU by the end of March, and it is expected to ship on February 15, but now it has dropped by 60% to 31 million doses.

　　The European Union has previously ordered 300 million doses of vaccine and has the right to order an additional 100 million doses.

Italy originally planned to obtain 8 million doses of Oxford vaccine in the first quarter of this year, but the current delivery volume is expected to be only 3.4 million doses.

　　Italian Prime Minister Conte criticized this practice as unacceptable, thinking that delaying the supply of vaccines amounts to a violation of the agreement and causing serious damage to Italy and other countries. He also threatened to take legal action.

　　Austria was expected to receive 2 million doses of the AstraZeneca vaccine in the first quarter, but now it can only get 600,000 doses.

Austrian Health Minister Anschöbel called this "very very bad news" and "completely unacceptable."

Irish Prime Minister Martin said: "This will disrupt our plan."

　　The vaccination schedules of European countries have been frustrated by Pfizer's supply cuts.

In a statement on the 15th, Pfizer stated that vaccine shipments were affected due to the company's adjustment of production processes to increase vaccine production.

　　Several EU countries stated that this situation is "unacceptable" and warned that it "reduces the credibility of the vaccination program."

Under pressure from the European Union, Pfizer finally issued a statement again saying that it will resume the normal supply of vaccines as originally planned from the 25th.